Alimentary pharmacology & therapeutics
-
Aliment. Pharmacol. Ther. · Nov 2005
Comparative StudyEvaluation of the Ez-HBT Helicobacter blood test to establish Helicobacter pylori eradication.
The urea blood test (Ez-HBT) has been shown to compare favourably with the urea breath test in the diagnosis of active Helicobacter pylori infection. ⋯ The performance characteristics of the Ez-HBT Helicobacter blood test are comparable with that of 13C-urea breath test in establishing H. pylori eradication after therapy. Errors related to incomplete fasting can be mitigated by collection of a basal blood sample.
-
Aliment. Pharmacol. Ther. · Nov 2005
ReviewReview article: the metabolic syndrome and non-alcoholic fatty liver disease.
Metabolic syndrome represents a common risk factor for premature cardiovascular disease and cancer whose core cluster includes diabetes, hypertension, dyslipidaemia and obesity. The liver is a target organ in metabolic syndrome patients in which it manifests itself with non-alcoholic fatty liver disease spanning steatosis through hepatocellular carcinoma via steatohepatitis and cirrhosis. ⋯ Studies are needed to highlight the grey areas in this topic. Issues to be addressed include: diagnostic criteria for metabolic syndrome; nomenclature of non-alcoholic fatty liver disease; enlargement of the clinical spectrum and characterization of the prognosis of insulin resistance-related diseases; evaluation of the most specific clinical predictors of metabolic syndrome/non-alcoholic fatty liver disease and assessment of their variability over the time; characterization of the importance of new risk factors for metabolic syndrome with regard to the development and progression of non-alcoholic fatty liver disease.
-
Aliment. Pharmacol. Ther. · Nov 2005
Randomized Controlled Trial Comparative StudyEffects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease.
Iron deficiency is a common complication of inflammatory bowel disease. Oral iron therapy may reinforce intestinal tissue injury by catalyzing production of reactive oxygen species. ⋯ Ferrous sulphate increased plasma malondialdehyde, a marker of lipid peroxidation. Comparing treatment with ferrous sulphate and iron-polymaltose complex, changes in plasma malondialdehyde tended to differ. Clinical disease activity was unchanged after both treatments.
-
Aliment. Pharmacol. Ther. · Nov 2005
Comparative StudyAerophagia in adults: a comparison with functional dyspepsia.
Aerophagia is a functional upper gastrointestinal disorder that has not previously been well described in a large patient group. ⋯ Individuals with aerophagia experience prolonged upper gastrointestinal symptoms. Initial presenting symptoms appear to be distinctly different from those who have functional dyspepsia.
-
Aliment. Pharmacol. Ther. · Oct 2005
Multicenter StudyCoeliac disease case finding and diet monitoring by point-of-care testing.
Immunoglobulin A class transglutaminase autoantibodies are highly predictive markers of active coeliac disease, a disorder difficult to recognize solely on clinical grounds. ⋯ Point-of-care testing was accurate in finding new coeliac cases and helped to identify and decrease dietary non-compliance.